Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus

Shock

Volumn 29, Issue 4, 2008, Pages 512-518

  Murphey, E D ^a,b   Fang, Geping ^a   Sherwood, Edward R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Bacterial infection; LPS; Monocytes macrophages; Rodent; Tolerance

Indexed keywords

ENDOTOXIN; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; INTERLEUKIN 10; STAPHYLOCOCCUS TOXIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; INNATE IMMUNITY; LIVER; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; SPLEEN; STAPHYLOCOCCUS AUREUS;

ANIMALS; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, NATURAL; INTERFERON TYPE II; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; SPLEEN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 40949114220     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318150776f     Document Type: Article

References (32)

1. Frassdorf J, Weber NC, Obal D, Toma O, Mullenheim J, Kojda G, Preckel B, Schlack W: Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappa B. Anesth Analg 101:934-941, 2005.
2. Meng XZ, Brown JM, Ao LH, Shames BD, Banerjee A, Harken AH: Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density. Shock 12:25-31, 1999.
3. Lastres-Becker I, Cartmell T, Molina-Holgado F: Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1 beta and TNF-alpha. J Neuroimmunol 173:108-116, 2006.
4. Furuya K, Zhu LD, Kawahara N, Abe O, Kirino T: Differences in infarct evolution between lipopolysaccharide-induced tolerant and nontolerant conditions to focal cerebral ischemia. J Neurosurg 103:715-723, 2005.
5. Gomes AS, Lima LMF, Santos CL, Cunha FQ, Ribeiro RA, Souza MHLP: LPS from Escherichia coli protects against indomethacin-induced gastropathy in rats - role of ATP-sensitive potassium channels. Eur J Pharmacol 547:136-142, 2006.
6. Konturek PC, Brzozowski T, Konturek SJ, Taut A, Kwiecien S, Pajdo R, Sliwowski Z, Hahn EG: Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins. Digestion 59:284-297, 1998.
7. Murphey ED, Fang GP, Varma TK, Sherwoodt ER: Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma. Shock 27:289-295, 2007.
8. Varma TK, Durham M, Murphey ED, Cui W, Huang Z, Lin CY, Toliver-Kinsky T, Sherwood ER: Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice. Infect Immun 73:7340-7347, 2005.
9. Pfaller MA, Jones RN, Doern GV, Kugler GVDK: Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 42:1762-1770, 1998.
10. Poltorak A, He XL, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088, 1998.
11. Cuschieri J, Billigren J, Maier RV: Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation. J Leukoc Biol 80:1289-1297, 2006.
12. Imler JL, Hoffmann JA: Toll receptors in innate immunity. Trends Cell Biol 11:304-311, 2001.
13. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S: Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 165:7096-7101, 2000.
14. Beeson PB: Tolerance to bacterial pyrogens: I. Factors influencing its development. J Exp Med 86:29-38, 1947.
15. Murphey ED, Traber DL: Protective effect of tumor necrosis factor-alpha against subsequent endotoxemia in mice is mediated, in part, by interleukin-10. Crit Care Med 29:1761-1766, 2001.
16. Ferlito M, Romanenko OG, Ashton S, Squadrito F, Halushka PV, Cook JA: Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1 beta on cellular signaling and mediator production. J Leukoc Biol 70:821-829, 2001.
17. Aneja R, Odoms K, Dunsmore K, Shanley TP, Wong HR: Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol 177:7184-7192, 2006.
18. Kilmartin B, Reen DJ: HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other pro-inflammatory stimuli. Eur J Immunol 34:2041-2051, 2004.
19. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T: Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J Immunol 166:5161-5167, 2001.
20. Wang JH, Doyle M, Manning BJ, Blankson S, Wu QD, Power C, Cahill R, Redmond HP: Bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J Immunol 170:14-18, 2003.
21. Abe M, Tokita D, Raimondi G, Thomson AW: Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol 36:2483-2493, 2006.
22. Bautista AP, Spitzer JJ: Cross-tolerance between acute alcohol intoxication and endotoxemia. Alcohol Clin Exp Res 20:1395-1400, 1996.
23. Jacinto R, Hartung T, McCall C, Li LW: Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 168:6136-6141, 2002.
24. Peck OM, Fan H, Tempel GE, Teti G, Halushka PV, Cook JA: Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. Shock 21:254-260, 2004.
25. Murphey ED, Sherwood ER: Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock 26:417-424, 2006.
26. Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ, van Der PT: IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166:6323-6331, 2001.
27. O'Brien GC, Wang JH, Redmond HP: Bacterial lipoprotein induces resistance to gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J Immunol 174:1020-1026, 2005.
28. Cohn ZA: Determinants of infection in the peritoneal cavity. Yale J Biol Med 35:29-47, 1962.
29. Guyton K, Bond R, Romeo C, Southern R, Cochran J, Teti G, Cook JA: Endotoxin-induced cross-tolerance to Gram-positive sepsis. J Endotoxin Res 5:119-126, 1999.
30. Ausobsky JR, Cheadle WG, Brosky BG, Polk HC: Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice. Br J Surg 71:151-153, 1984.
31. Brooks JC, Hoskin DW: The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR. Transplantation 58:1096-1103, 1994.
32. Kusmartsev SA, Li Y, Chen SH: Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 165:779-785, 2000.